Able Laboratories, Inc. is a rapidly growing developer and manufacturer of generic pharmaceuticals in tablet, capsule and suppository dosage forms. Able's focus is to develop products that offer attractive market opportunities within selected niche markets of the generic drug industry. In addition to one New Drug Application approval (NDA), the Company received 31 Abbreviated New Drug Application approvals (ANDAs), and has several ANDAs pending FDA approval.
With a total commitment to quality and service, and a robust pipeline of new products in development, Able is strategically positioned to meet and exceed the needs and expectations of its customers and the consumer.
ablelabs.com |
